Traders should monitor the May 7 earnings release and call for updates on revenue, operating performance, and guidance. Until then, no new financial or strategic information is available.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 16 $6.62entry
- T+1 · 7mo ago +0.45%α −0.76% · $6.65
- T+5 · 7mo ago +1.96%α +0.98% · $6.75
- T+20 · 6mo ago +7.25%α +1.44% · $7.10
- T+60 · 4mo ago +8.01%α +0.96% · $7.15
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Profound Medical Corp. announced it will release its first quarter 2026 financial results on May 7, 2026, after market close, followed by a conference call at 4:30 p.m. ET to review the results and discuss business developments. No financial data or guidance was provided in this filing.
Key Facts
- Profound Medical will release Q1 2026 financial results on May 7, 2026, after market close.
- Management will host a conference call on May 7, 2026, at 4:30 p.m. ET to discuss results and business developments.
- No financial results, guidance, or material updates were disclosed in this filing.
Financial Impact
None disclosed, this filing only announces the upcoming earnings release and conference call.
Risk Factors
- Market volatility may occur ahead of the May 7 earnings release due to lack of forward-looking statements in this filing.
- No indication of performance direction (positive or negative) was provided, increasing uncertainty.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001171843-26-002497 |
| Exhibit: exh_991.htm | 0001171843-26-002497 |
| Document: 0001171843-26-002497-index-headers.html | 0001171843-26-002497 |
| Document: 0001171843-26-002497-index.html | 0001171843-26-002497 |
| Document: 0001171843-26-002497.txt | 0001171843-26-002497 |
Track record
22 reports on PROF
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +25.61% at T+60 after the Mar 5, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Neutral 3/10 Entry $7.44 Now $7.34 −1.34% settles Dec 11
- Nov 9, 20267d ago 8-K Neutral 2/10 Entry $7.34 Now $7.34 +0.00% settles Dec 8
- Nov 5, 202611d ago 8-K Bearish 5/10 Entry $7.21 Now $7.34 −1.80% settles Dec 7
- Nov 3, 202613d ago 8-K Neutral 4/10 Entry $7.16 Now $7.34 +2.51% settles Dec 3
- Oct 30, 202617d ago Press Release Neutral 4/10 Entry $6.57 Now $7.34 +11.72% settles Nov 30
- Oct 22, 202625d ago 8-K Neutral 2/10 Entry $5.56 Now $7.34 +32.01% settles Nov 20
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $6.62 to $7.68 Now $7.34 +10.88% ▲ +16.01% +18.57% vs SPY
- Oct 9, 20265w ago 8-K Neutral 3/10 Entry $6.90 to $7.01 Now $7.34 +6.38% ▲ +1.59% +7.15% vs SPY
- Oct 7, 20265w ago 8-K Bullish 7/10 Entry $6.91 to $7.16 Now $7.34 +6.22% ▲ +3.62% +8.91% vs SPY
- Sep 3, 202610w ago 8-K Neutral 2/10 Entry $6.89 to $6.03 Now $7.34 +6.53% ▼ −12.48% −13.08% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers